Jetema Co

Jetema Co Diluted EPS

The Diluted Earnings per Share of Jetema Co (216080.KQ) as of Oct 23, 2026 is -177.45 KRW. In the previous year, Diluted Earnings per Share was -5.26 KRW — a change of 3,273.10% (lower).

Diluted EPS

-177.45KRW

YoY

3,273.10%

Last updated:

Diluted Earnings per Share of Jetema Co is 2025 -177.45 KRW. Diluted Earnings per Share of Jetema Co was 2024 -5.26 KRW. It decreases by 3,273.10% lower compared to the previous year.

The Jetema Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-2,765.95 KRW
Jan 1, 2019
-906.79 KRW
Jan 1, 2020
-530.95 KRW
Jan 1, 2021
612.64 KRW
Jan 1, 2022
81.68 KRW
Jan 1, 2023
782.55 KRW
Jan 1, 2024
-5.26 KRW
Jan 1, 2025
-177.45 KRW
The Jetema Co Diluted EPS history
YEARDiluted EPSYoY
-177.45KRW+3,273.10%
-5.26KRW-100.67%
782.55KRW+858.05%
81.68KRW-86.67%
612.64KRW-215.38%
-530.95KRW-41.45%
-906.79KRW-67.22%
-2,765.95KRW+167.03%
-1,035.82KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jetema Co Stock analysis

What does Jetema Co do? Jetema Co., Ltd. generates revenue through the manufacturing and distribution of aesthetic products such as dermal fillers, threads, botulinum toxin, and other medical devices. The company develops and sells hyaluronic acid fillers for facial beauty, medical devices for wrinkle, contour, and volume improvement, and laser equipment for treating leukoplakia, psoriasis, and alopecia areata. Additional products include the lifting medical device epiticons, cosmetic mask packs, and pharmaceutical excaine creams. The primary buyers are medical professionals and clinics seeking cosmetic and dermatological solutions. The company's product portfolio targets the aesthetic and medical device market segments, focusing on non-surgical beauty treatments and skin condition therapies. Jetema Co., Ltd. serves customers in the healthcare sector who require advanced medical devices for cosmetic procedures and dermatological care. The business model centers on direct sales of these specialized medical products to healthcare providers and clinics. Jetema Co., Ltd. operates with a workforce of 187 full-time employees based in Wonju, Gangwon-Do, and has been engaged in the development and manufacturing of hyaluronic acid fillers since its inception. The company's offerings are designed to address specific medical and cosmetic needs, with a focus on facial beauty and skin treatments. Revenue is derived from the sale of these medical devices and related products to healthcare professionals and clinics. Jetema Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jetema Co stock

Diluted Earnings per Share of Jetema Co is -177.45 KRW in 2025.

Diluted Earnings per Share of Jetema Co changed from -5.26 KRW to -177.45 KRW, representing a 3,273.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Jetema Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Jetema Co

All Key Metrics — Jetema Co